William Blair & Company initiated research coverage of Phreesia, Inc. (PHR $27.37), an HCIT provider of software-as-a-service solutions to help healthcare providers manage mission-critical processes, including patient intake, revenue cycle management, and patient engagement. Analyst Ryan Daniels estimates the company can generate fiscal 2020 total revenue of $116.9 million, adjusted EBITDA of $2.5 million, and an adjusted loss per share of $0.38; for fiscal 2021, he projects revenue of $139.4 million, adjusted EBITDA of $6.4 million, and an adjusted loss per share of $0.23. Daniels said, `Phreesia was founded to capitalize on the opportunity to leverage technology to automate patient...
|
